Saturday, 01 August 2015

Dr Michael Makanga designated as next EDCTP Executive Director
During its last meeting, the General Assembly of the European & Developing Countries Clinical Trials Partnership (EDCTP) selected Dr Michael Makanga to succeed Professor Charles Mgone as Executive Director. Prof. Mgone, who has been Executive Director for eight years, had decided to step down at the end of 2015 in order to pursue other interests. Dr Makanga will take up his role from 1 January 2016.

Dr Michael Makanga is a clinician-scientist born and raised in Uganda with (after medical qualification) 24 years of professional experience of working on health and poverty related diseases in sub-Saharan Africa. This includes 20 years of work experience on medical product development and clinical regulatory activities. He holds a Medical Degree from Makerere University, Uganda, and has been in various clinical and research positions before and after undertaking an MSc at the University of Liverpool, and then a PhD at the Liverpool School of Tropical Medicine, United Kingdom.


Read more...
more Media and News articles..
EDCTP Newsletter May 2015

Please find the May 2015 update from EDCTP, including the current grant calls expiring 18th June 2015 and the communication from the outgoing EDCTP ED, Prof. Charles Mgone Download Full Newsletter Here 

 
more Research articles..
Marburg Hemorrhagic Fever

Marburg Hemorrhagic Fever Facts




What is Marburg hemorrhagic fever?
Marburg hemorrhagic fever (Marburg HF) is a rare, severe type of hemorrhagic fever which affects both humans and non-human primates. Caused by a genetically unique zoonotic (that is, animal-borne) RNA virus of the filovirus family, its recognition led to the creation of this virus family. The five subtypes of Ebola virus are the only other known members of the filovirus family.
Marburg virus was first recognized in 1967, when outbreaks of hemorrhagic fever occurred simultaneously in laboratories in Marburg and Frankfurt, Germany and in Belgrade, Yugoslavia (now Serbia). A total of 31 people became ill; they included laboratory workers as well as several medical personnel and family members who had cared for them. There were 7 deaths among the reported cases. The first people infected had been exposed to African green monkeys or their tissues. In Marburg, the monkeys had been imported for research and to prepare polio vaccine. In addition to the 31 cases, an additional primary case was retrospectively serologically diagnosed.


Read more...
more Rapid Response articles..
MANDATE

The UVRI engages in health research pertaining to human infections and disease processes associated with or linked to viral aetiology and provides expert advice, enables partnerships and communication and serves as a center for training and education.

Read more...
VISION AND MISSION

To be a world class center of excellence in health research.

To conduct scientific investigations on viral and other communicable diseases so as to contribute to knowledge, policy, practice and build capacity while promoting institutional sustainability.......

Read more...
ON CAMPUS COLLABORATORS

The UVRI team implements various programmes with various organizations on its Entebbe Campus and other sites.

Medical Research Council

The MRC/UVRI Uganda Research Unit on AIDS part of the UK Medical Research Council (MRC),

Read more...
Loading...
Select UVRI Video to watch
OUR
PARTNERS

                                                   

More Partners